Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Amortization of Deferred Charges (2015 - 2019)

Medpace Holdings' (MEDP) quarterly Amortization of Deferred Charges came in at $700000.0 in Q3 2019, up 354.55% on a YoY basis from $154000.0 in Q3 2018, and down 4.89% quarter-over-quarter from $736000.0 in Q2 2019.

Analysis

Medpace Holdings (MEDP) Amortization of Deferred Charges (2015 - 2019) Analysis & Trends

Medpace Holdings (MEDP) has reported Amortization of Deferred Charges for 5 consecutive years, with $700000.0 the latest figure, recorded in Q3 2019.

  • For the quarter ending Q3 2019, Amortization of Deferred Charges rose 354.55% year-over-year to $700000.0; the trailing twelve-month figure through Jun 2020 stood at $700000.0 (down 40.27% YoY), and the FY2019 full-year result was $954000.0, up 55.12% from the prior year.
  • Amortization of Deferred Charges declined to $700000.0 in Q3 2019 per MEDP's latest filing, from $736000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $736000.0 in Q2 2019 and bottomed at $138000.0 in Q1 2019.
  • Historically, Amortization of Deferred Charges has averaged $381625.0 across 5 years, with a median of $166500.0 in 2017.
  • The sharpest annual moves came in 2017 and 2019: Amortization of Deferred Charges slumped 75.55% in 2017, then surged 365.82% in 2019.
  • Over 5 years, Amortization of Deferred Charges stood at $679000.0 in 2015, then declined by 18.7% to $552000.0 in 2016, then tumbled by 70.29% to $164000.0 in 2017, then fell by 12.2% to $144000.0 in 2018, then surged by 386.11% to $700000.0 in 2019.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $700000.0, $736000.0, and $138000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 700,000.00
Jun 30, 2019 736,000.00
Mar 31, 2019 138,000.00
Dec 31, 2018 144,000.00
Sep 30, 2018 154,000.00
Jun 30, 2018 158,000.00
Mar 31, 2018 159,000.00
Dec 31, 2017 164,000.00
Sep 30, 2017 166,000.00
Jun 30, 2017 167,000.00
Mar 31, 2017 165,000.00
Dec 31, 2016 552,000.00
Sep 30, 2016 679,000.00
Jun 30, 2016 673,000.00
Mar 31, 2016 672,000.00
Dec 31, 2015 679,000.00